Kevin H Mayo

Huijbers, E. J. M., van Beijnum, J. R., Lê, C. T., Langman, S., Nowak-Sliwinska, P., Mayo, K. H. & Griffioen, A. W., Jul 9 2019, In : Vaccine. 37, 30, p. 4231-4232 2 p.

Research output: Contribution to journal › Comment/debate

Open Access

Conjugate Vaccines

Cancer Vaccines

Antibody Formation

vaccines

Technology

1 Citation (Scopus)

Galectin-3 binds selectively to the terminal, non-reducing end of β(1→4)-galactans, with overall affinity increasing with chain length

Miller, M. C., Zheng, Y., Zhou, Y., Tai, G. & Mayo, K. H., Jan 1 2019, In : Glycobiology. 29, 1, p. 74-84 11 p.

Research output: Contribution to journal › Article

Galactans

Galectin 3

Chain length

Carbohydrates

Galectins

6 Citations (Scopus)

Adhesion/growth-regulatory galectins tested in combination: Evidence for formation of hybrids as heterodimers

Miller, M. C., Ludwig, A. K., Wichapong, K., Kaltner, H., Kopitz, J., Gabius, H. J. & Mayo, K. H., Mar 15 2018, In : Biochemical Journal. 475, 5, p. 1003-1018 16 p.

Research output: Contribution to journal › Article

Galectins

Adhesion

Galectin 1

Galectin 3

Growth

3 Citations (Scopus)

An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature

Huijbers, E. J. M., van Beijnum, J. R., Lê, C. T., Langman, S., Nowak-Sliwinska, P., Mayo, K. H. & Griffioen, A. W., May 17 2018, In : Vaccine. 36, 21, p. 3054-3060 7 p.

Research output: Contribution to journal › Article

Conjugate Vaccines

Thioredoxins

Antibody Formation

Autoantigens

vaccines

9 Citations (Scopus)

Galectins as molecular targets for therapeutic intervention

Dings, R. P. M., Miller, M. C., Griffin, R. J. & Mayo, K. H., Mar 19 2018, In : International journal of molecular sciences. 19, 3, 905.

Research output: Contribution to journal › Review article

Open Access

Galectins

cancer

effectors

Epitopes

Biological Phenomena